Iopamiro

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast agent presented as an injectable solution for intraarterial, intrauterine, and intravenous use. It enhances radiographic visualization of vascular and tissue structures during diagnostic imaging procedures in patients requiring detailed anatomical assessment.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic imaging centres and procurement teams worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable supply chains and responsive technical support.

Iopamiro, an iodinated contrast agent, is used in radiographic procedures that require enhanced visualization of vascular and organ structures. - Angiography: provides high‑contrast images of blood vessels to aid diagnosis and interventional planning. - Computed tomography (CT) imaging: improves delineation of soft‑tissue and vascular anatomy during CT scans. - Urography: enhances visualization of the urinary tract for functional and structural assessment. - Arthrography: facilitates detailed imaging of joint spaces and cartilage. - Hysterosalpingography: highlights the uterine cavity and fallopian tubes for fertility evaluation.

Iopamiro may be associated with a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Warmth or flushing at the injection site. - Mild nausea or vomiting. - Transient headache. - Metallic taste in the mouth. - Mild itching or urticaria.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with respiratory distress. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiovascular collapse or hypotension. - Seizures or neurological disturbances. - Persistent vomiting leading to dehydration.

Prior to administering Iopamiro, clinicians should observe several safety precautions to minimize risk. - Assess renal function: evaluate serum creatinine and eGFR before use. - Review allergy history: avoid in patients with known hypersensitivity to iodinated contrast. - Hydration status: ensure adequate hydration to reduce nephrotoxicity risk. - Concomitant nephrotoxic drugs: discontinue or adjust dosage of agents such as NSAIDs or aminoglycosides when possible. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Store at controlled room temperature: keep the vial in the original packaging, protect from light and freeze, and store below 25 °C.

Iopamiro can interact with other medications, influencing its safety or efficacy.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: may increase cumulative iodine load and risk of adverse reactions. - High‑dose metformin in patients with renal impairment: risk of lactic acidosis; discontinue metformin before and after contrast administration.

Moderate Interactions (Monitor Closely): - Nephrotoxic drugs (e.g., NSAIDs, amphotericin B): monitor renal function closely. - Thyroid hormone therapy: iodine load may affect thyroid function tests. - Beta‑blockers: may mask signs of anaphylactoid reactions. - Diuretics: may exacerbate fluid shifts; assess volume status. - ACE inhibitors or ARBs: consider temporary suspension in high‑risk renal patients.